Literature DB >> 10395800

Cloning and genomic organization of beclin 1, a candidate tumor suppressor gene on chromosome 17q21.

V M Aita1, X H Liang, V V Murty, D L Pincus, W Yu, E Cayanis, S Kalachikov, T C Gilliam, B Levine.   

Abstract

The beclin 1 (BECN1) gene encodes a 60-kDa coiled-coil protein that interacts with the prototypic apoptosis inhibitor Bcl-2. Previous studies indicate that beclin 1 maps to a region approximately 150 kb centromeric to BRCA1 on chromosome 17q21 that is commonly deleted in breast, ovarian, and prostate cancer. The complete cDNA sequence of beclin 1 encodes a 2098-bp transcript, with a 120-bp 5' UTR, 1353-bp coding region, and 625-bp 3' UTR. Hybridization screening of a human genomic PAC library identified PAC 452O8, which contains the complete beclin 1 gene. Determination of the exon-intron structure of beclin 1 reveals 12 exons, ranging from 61 to 794 bp, which extend over 12 kb of the human genome. FISH analysis of human breast carcinoma cell lines using PAC 452O8 as probe identified allelic beclin 1 deletions in 9 of 22 cell lines. Sequencing of genomic DNA from 10 of these cell lines revealed no mutations in coding regions or splice junctions. Additionally, Northern blot analysis of 11 cell lines did not identify any abnormalities in beclin 1 transcripts. These results indicate that human breast carcinoma cell lines frequently contain allelic deletions of beclin 1, but not beclin 1 coding mutations. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10395800     DOI: 10.1006/geno.1999.5851

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  305 in total

1.  Use of chromatin immunoprecipitation to clone novel E2F target promoters.

Authors:  A S Weinmann; S M Bartley; T Zhang; M Q Zhang; P J Farnham
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

Review 2.  Autophagy and cancer.

Authors:  Li Yen Mah; Kevin M Ryan
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-01-01       Impact factor: 10.005

3.  Mitochondrial dysfunction in ataxia-telangiectasia.

Authors:  Yasmine A Valentin-Vega; Kirsteen H Maclean; Jacqueline Tait-Mulder; Sandra Milasta; Meredith Steeves; Frank C Dorsey; John L Cleveland; Douglas R Green; Michael B Kastan
Journal:  Blood       Date:  2011-12-05       Impact factor: 22.113

4.  Blocking NF-κB nuclear translocation leads to p53-related autophagy activation and cell apoptosis.

Authors:  Bao-Song Zhu; Chun-Gen Xing; Fang Lin; Xiao-Qing Fan; Kui Zhao; Zheng-Hong Qin
Journal:  World J Gastroenterol       Date:  2011-01-28       Impact factor: 5.742

Review 5.  The crosstalk between autophagy and apoptosis: where does this lead?

Authors:  Claire Gordy; You-Wen He
Journal:  Protein Cell       Date:  2012-02-09       Impact factor: 14.870

6.  Effect of icarisid II on diabetic rats with erectile dysfunction and its potential mechanism via assessment of AGEs, autophagy, mTOR and the NO-cGMP pathway.

Authors:  Jian Zhang; Ai-Min Li; Bao-Xing Liu; Fei Han; Feng Liu; Shao-Peng Sun; Xin Li; Shu-Jin Cui; Shao-Zhong Xian; Guang-Qi Kong; Zhong-Cheng Xin; Zhi-Li Ji
Journal:  Asian J Androl       Date:  2012-06-25       Impact factor: 3.285

Review 7.  Autophagy, Metabolism, and Cancer.

Authors:  Eileen White; Janice M Mehnert; Chang S Chan
Journal:  Clin Cancer Res       Date:  2015-11-15       Impact factor: 12.531

Review 8.  Autophagy regulation in the development and treatment of breast cancer.

Authors:  Yuting Zhou; Edmund B Rucker; Binhua P Zhou
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2015-12-05       Impact factor: 3.848

9.  Upregulation of Beclin-1 expression in DU-145 cells following low-frequency ultrasound irradiation combined with microbubbles.

Authors:  Y U Wang; Yi-Ni Chen; Wei Zhang; Y U Yang; E Shen; Bing Hu
Journal:  Oncol Lett       Date:  2015-07-17       Impact factor: 2.967

10.  Targeting Autophagy Sensitizes BRAF-Mutant Thyroid Cancer to Vemurafenib.

Authors:  Weibin Wang; Helen Kang; Yinu Zhao; Irene Min; Brian Wyrwas; Maureen Moore; Lisong Teng; Rasa Zarnegar; Xuejun Jiang; Thomas J Fahey
Journal:  J Clin Endocrinol Metab       Date:  2017-02-01       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.